blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3145508

EP3145508 - CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.05.2024
Database last updated on 31.03.2026
FormerThe patent has been granted
Status updated on  02.06.2023
FormerGrant of patent is intended
Status updated on  09.01.2023
FormerExamination is in progress
Status updated on  26.06.2020
FormerRequest for examination was made
Status updated on  24.02.2017
FormerThe international publication has been made
Status updated on  16.12.2016
Most recent event   Tooltip05.09.2025Lapse of the patent in a contracting state
New state(s): CY, HU		published on 08.10.2025  [2025/41]
Applicant(s)For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo, 26/A
43122 Parma / IT
[2021/17]
Former [2020/27]For all designated states
Chiesi Farmaceutici S.p.A.
Via Palermo 26/A
43122 Parma / IT
Former [2017/20]For all designated states
Chiesi Farmaceutici S.p.a.
Via Palermo, 26A
43122 Parma / IT
Former [2017/13]For all designated states
The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 / US
Inventor(s)01 / MOTHERAM, Rajeshwar
17 Summerfield Boulevard
Dayton, NJ 08810 / US
02 / HANLEY, Sr. David C.
86 Whisconier Road
Brookfield, CT 06804 / US
03 / TÜRELI, Akif Emre
Industriestrasse 28
66740 Saarlouis / DE
04 / KANTER, Monika
Am Ehrenmal 2
54439 Saarburg / DE
 [2017/13]
Representative(s)Bianchetti & Minoja with Trevisan & Cuonzo IPS SRL
Via Plinio, 63
20129 Milano / IT
[2023/27]
Former [2017/13]Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
Application number, filing date15795707.719.05.2015
[2017/13]
WO2015US31470
Priority number, dateUS201462000119P19.05.2014         Original published format: US 201462000119 P
[2017/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015179334
Date:26.11.2015
Language:EN
[2015/47]
Type: A1 Application with search report 
No.:EP3145508
Date:29.03.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 26.11.2015 takes the place of the publication of the European patent application.
[2017/13]
Type: B1 Patent specification 
No.:EP3145508
Date:05.07.2023
Language:EN
[2023/27]
Search report(s)International search report - published on:US26.11.2015
(Supplementary) European search report - dispatched on:EP21.12.2017
ClassificationIPC:A61K9/10, A61K9/19, A61K9/51, A61K47/10, A61K31/4422
[2018/03]
CPC:
A61K9/5123 (EP,KR,US); A61K9/51 (RU); A61K31/4422 (EP,KR,RU,US);
A61K47/10 (EP,KR,US); A61K9/0019 (EP,KR,US); A61K9/10 (KR);
A61P9/12 (RU); B82Y5/00 (RU) (-)
Former IPC [2017/13]A61K31/4422
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/13]  
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:CLEVIDIPINNANOPARTIKEL UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS[2017/13]
English:CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF[2017/13]
French:NANOPARTICULES DE CLÉVIDIPINE ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT[2017/13]
Entry into regional phase15.12.2016National basic fee paid 
15.12.2016Search fee paid 
15.12.2016Designation fee(s) paid 
15.12.2016Examination fee paid 
Examination procedure15.12.2016Examination requested  [2017/13]
15.12.2016Date on which the examining division has become responsible
13.07.2018Amendment by applicant (claims and/or description)
30.06.2020Despatch of a communication from the examining division (Time limit: M06)
23.12.2020Reply to a communication from the examining division
10.01.2023Communication of intention to grant the patent
10.05.2023Fee for grant paid
10.05.2023Fee for publishing/printing paid
10.05.2023Receipt of the translation of the claim(s)
Opposition(s)08.04.2024No opposition filed within time limit [2024/24]
Fees paidRenewal fee
30.05.2017Renewal fee patent year 03
29.05.2018Renewal fee patent year 04
28.05.2019Renewal fee patent year 05
27.05.2020Renewal fee patent year 06
27.05.2021Renewal fee patent year 07
27.05.2022Renewal fee patent year 08
30.05.2023Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY19.05.2015
HU19.05.2015
CZ05.07.2023
HR05.07.2023
MC05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
NO05.10.2023
IS05.11.2023
[2025/41]
Former [2025/07]CZ05.07.2023
HR05.07.2023
MC05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
NO05.10.2023
IS05.11.2023
Former [2024/23]CZ05.07.2023
HR05.07.2023
RO05.07.2023
RS05.07.2023
SK05.07.2023
SM05.07.2023
NO05.10.2023
IS05.11.2023
Former [2024/20]HR05.07.2023
RS05.07.2023
SM05.07.2023
NO05.10.2023
IS05.11.2023
Former [2024/10]HR05.07.2023
RS05.07.2023
NO05.10.2023
IS05.11.2023
Former [2024/08]NO05.10.2023
Documents cited:Search[XY] CN103479577  (UNIV SHANDONG et al.) [X] 1-14,18,19 * page 1, paragraph 1 * * examples 1-9 * * claims 1-5, 8-10 *[Y] 12-19
 [Y] US2012088804  (MOTHERAM RAJESHWAR et al.) [Y] 12-19 * claims 7, 11 *
 [Y] US2014121247  (SPINDLER JR EDWARD C et al.) [Y] 12-19 * paragraphs [0056] - [0059] * * claim 1 *
International search[XY] CN103479577  (UNIV SHANDONG et al.) [X] 1, 4, 6, 8-15, 18-21 * ; paragraphs [0001], [0022], [0046], [0050] *[Y] 2-3, 5, 7, 16-17, 22-37
 [Y] WO2013030725  (WOCKHARDT LTD et al.) [Y] 2-3 * ; claims 1, 3, 13 *
 [Y] US2013243886  (HU YANMIN et al.) [Y] 5, 7 * ; paragraphs [0373], [0376], [0378] *
 [Y] US2014127311  (BECK-BROICHSITTER MORITZ et al.) [Y] 16-17 * ; abstract *
 [Y] US2013012551  (BAUMSTUEMMLER BERND et al.) [Y] 22, 29 * ; abstract; paragraphs [0048]-[0049] *
 [Y] US2014121247  (SPINDLER JR EDWARD C et al.) [Y] 23-37 * ; abstract; paragraphs [0008]-[0009], [0014]-[0015], [0045], [0057] *
 [Y] US2012088804  (MOTHERAM RAJESHWAR et al.) [Y] 36-37 * ; paragraphs [0028]-[0029], [0057] *
 [A] US2013158079  (MOTHERAM RAJESHWAR et al.) [A] 1-37 * ; entire document *
 [A] US2012322835  (MOTHERAM RAJESHWAR et al.) [A] 1-37 * ; entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.